A

Alethiomics

8 employees

Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Myelofibrosis
Blood cancer
Therapeutics
Mutli-omics
Myeloproliferative neoplasms
Drug discovery
Single cell sequencing

Date founded

2021

Funding rounds raised

Total raised

$8M

from 1 investors over 1 rounds

A

Alethiomics raised $8M on December 15, 2021

Investors: Oxford Sciences Innovation

FAQ